Tarsons Products Limited has officially appointed Mr. Vinesh Mohan Kriplani as Non-Executive Independent Director following the successful completion of its postal ballot process. The company submitted the appointment intimation to BSE Limited and National Stock Exchange of India Limited on April 08, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Appointment Details

The appointment becomes effective from February 06, 2026, for a term of five consecutive years. Mr. Kriplani will serve as a Non-Executive Independent Director and will not be liable to retire by rotation, as approved by the company's members through postal ballot.

Postal Ballot Results Overview

The postal ballot received exceptional shareholder support with overwhelming approval from members. The resolution was passed as a Special Resolution through remote e-voting facility provided by National Securities Depository Limited (NSDL).

Director Profile and Expertise

Mr. Vinesh Mohan Kriplani brings extensive experience as a Chartered Accountant with over 29 years of expertise in Indian corporate and international taxation. He specializes in mergers and acquisitions, corporate restructuring, and cross-border transactions.

Category-wise Voting Analysis

The voting pattern demonstrated strong support across all shareholder categories, with promoter group and public institutions showing unanimous approval for the appointment.

Regulatory Compliance and Process

Ms. Manisha Saraf, Company Secretary in Practice (FCS: 7607, C.P. No.: 8207), served as the appointed Scrutinizer and confirmed that the voting process was conducted in a fair and transparent manner. The postal ballot process followed a structured timeline with the cut-off date set as February 27, 2026, and e-voting conducted from March 07, 2026 to April 06, 2026.

The submission was signed by Santosh Kumar Agarwal, CFO, Company Secretary and Compliance Officer (ICSI Membership No. A44836), ensuring proper regulatory compliance and transparency for all stakeholders. Mr. Kriplani is not related to any existing Director of the Company and is not debarred from holding directorial positions by SEBI or any other authority.

Tarsons Products Limited has announced that CARE has reaffirmed the credit ratings for its bank loan facilities through a press release dated March 30, 2026. The company informed stock exchanges about this development on March 31, 2026, in compliance with SEBI listing regulations.

Credit Rating Details

CARE has maintained stable ratings across all facility categories for Tarsons Products. The rating reaffirmation covers total bank facilities worth ₹612.73 crores across different categories.

Facility Amount Changes

The rating reaffirmation came with notable changes in facility amounts. Long-term bank facilities were reduced from ₹516.02 crores to ₹500.73 crores, representing a decrease of ₹15.29 crores. Similarly, the long-term/short-term bank facilities saw a marginal reduction from ₹25.00 crores to ₹24.00 crores.

Conversely, short-term bank facilities were significantly enhanced from ₹39.00 crores to ₹84.00 crores, more than doubling the available facility amount. The company also received a new assignment of ₹4.00 crores in short-term bank facilities with a CARE A1 rating.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Santosh Kumar Agarwal, who serves as CFO, Company Secretary and Compliance Officer, signed the regulatory filing. The company has also made this information available on its website at www.tarsons.com for stakeholder reference.